ENTRADA THERAPEUTICS INC
TRDA·29384C108·US·Common Stock·Healthcare - Biotechnology-Activist
TRDA (ENTRADA THERAPEUTICS INC) is held by 81 institutional investors as of Q2 2026. Largest holders: BAKER BROS. ADVISORS LP ($37.3M), BlackRock, Inc. ($19M), VANGUARD CAPITAL MANAGEMENT LLC ($9.3M). Net institutional sentiment: Mixed.
81
Holders
(6 Elite)
$137.1M
Total Value
60% (81)
Consensus
49 buying - 32 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Sep 9, 2026 · Activists Sep 10, 2026 · Congress none
ActivistMBMPM BioVentures 2014, L.P.4.5%Sep 10, 2026
InsiderMLMPM BIOVENTURES 2018, L.P.Sell $206KSep 9, 2026
InsiderMLMPM BioVentures 2014, L.P.Sell $206KSep 9, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 89
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer